King Tracy A, King Madeline T, White Kate J
Semin Oncol Nurs. 2017 Aug;33(3):299-315. doi: 10.1016/j.soncn.2017.05.006. Epub 2017 Jul 12.
To review the current state of evidence for the use of patient-reported outcomes (PROs) and health-related quality of life (HRQoL) in optimizing best supportive care for patients with multiple myeloma (MM).
Peer-reviewed journal articles, research reports, state of the science papers, and clinical guidelines.
The diagnosis and treatment of MM negatively impacts an individual's HRQoL. Validated self-report tools that assess HRQoL and other PROs provide an insight into how the treatment or disease is impacting the individual, enabling early recognition of physical and emotional concerns. There is a growing body of evidence to support the use of PROs in assessing HRQoL in MM in clinical care.
There is a clear benefit for nurses to utilize PROs for patients with MM in order to obtain an understanding of how the treatment effects HRQoL. Thoughtful use of PRO measures can enable nurses to individualize supportive care interventions to meet the specific needs of the patient, and facilitate timely access to optimal symptom support.
回顾关于使用患者报告结局(PROs)和健康相关生活质量(HRQoL)来优化多发性骨髓瘤(MM)患者最佳支持治疗的现有证据状况。
同行评审期刊文章、研究报告、科学现状论文及临床指南。
MM的诊断和治疗对个体的HRQoL有负面影响。经过验证的评估HRQoL及其他PROs的自我报告工具能深入了解治疗或疾病如何影响个体,有助于早期识别身体和情感问题。越来越多的证据支持在临床护理中使用PROs评估MM患者的HRQoL。
护士利用PROs评估MM患者有明显益处,以便了解治疗如何影响HRQoL。谨慎使用PRO测量方法可使护士将支持性护理干预个体化,以满足患者的特定需求,并促进及时获得最佳症状支持。